Development of novel medicines using high resolution native mass spectrometry of intact protein assemblies
OMass is an Oxford University spin-out that is harnessing high-resolution native mass spectrometry and other biophysical technologies to drive drug discovery in high definition for immunology and genetic disease.
Date: 7 September 2021, 12:00 (Tuesday, 20th week, Trinity 2021)